Traduction de «clinical sign disease » (Anglais → Français) :

clinical signs of disease

An extremely rare genetic glycogen storage disease reported in one patient to date. Clinical signs included muscle weakness, cardiac arrhythmia associated with accumulation of abnormal storage material in the heart and glycogen depletion in skeletal

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

autoimmunity | pathology of a disease in relation to immune system | clinical immunology | diseases caused by disorders of the immune system

Disease with characteristics of early-onset of cerebellar signs with eye movement abnormalities and a very slow disease progression.Three families have been reported to date. Clinical manifestations include cerebellar signs (ataxia, dysarthria, and i

Disease with characteristics of early-onset cerebellar signs, eye movement abnormalities and pyramidal signs. Fifty-one clinically affected members from four families (of British, Pakistani, German and French descent) have been reported to date. The

Definition: A disorder in which the main feature is a serious impairment in the development of motor coordination that is not solely explicable in terms of general intellectual retardation or of any specific congenital or acquired neurological disorder. Nevertheless, in most cases a careful clinical examination shows marked neurodevelopmental immaturities such as choreiform movements of unsupported limbs or mirror movements and other associated motor features, as well as signs ...[+++] of impaired fine and gross motor coordination. | Clumsy child syndrome Developmental:coordination disorder | dyspraxia

Symptoms, signs and abnormal clinical and laboratory findings

66. Calls on the Member States, as far as the training of medical and paramedical personnel is concerned, to highlight the differences in the clinical signs and symptoms of cardiovascular diseases occurring in women, stressing the benefits of prompt intervention;

that milk and colostrum from animals showing clinical signs of udder disease are not used for human consumption otherwise than in accordance with the instructions of a veterinarian.

1. Member States shall ensure that aquaculture animals placed on the market for farming do not come from a farm or mollusc farming area where there has been any increased mortality or a clinical outbreak of any disease within 31 days prior to the date of placing on the market, unless such animals originate from a part of the farm or mollusc farming area epidemiologically independent of the part where the increased mortality or clinical signs of disease have occurred.

1. Member States shall ensure that aquaculture animals placed on the market for farming are clinically healthy and do not come from a farm or mollusc farming area where there is any unresolved increased mortality unless such animals originate from a part of the farm or mollusc farming area independent of the epidemiological unit where the increased mortality or clinical signs of disease have occurred.